Literature DB >> 11463637

Osmotically induced membrane tension modulates membrane permeabilization by class L amphipathic helical peptides: nucleation model of defect formation.

I V Polozov1, G M Anantharamaiah, J P Segrest, R M Epand.   

Abstract

The mechanism of action of lytic peptides on membranes is widely studied and is important in view of potential medical applications. Previously (I. V. Polozov, A. I. Polozova, E. M. Tytler, G. M. Anantharamaiah, J. P. Segrest, G. A. Woolley, and R. M., Biochemistry, 36:9237--9245) we analyzed the mechanism of membrane permeabilization by 18L, the archetype lytic peptide featuring the class L amphipathic alpha-helix, according to the classification of Segrest et al. (J. P. Segrest, G. de Loof, J. G. Dohlman, C. G. Brouillette, and G. M. Anantharamaiah, 1990, Proteins, 8:103--117). We concluded that the 18L peptide destabilizes membranes, leading to a transient formation of large defects that result in contents leakage and, in the presence of bilayer-bilayer contact, could lead to vesicle fusion. Here we report that this defect formation is strongly enhanced by the membrane tension induced by osmotic swelling of vesicles. Even below standard leakage-inducing peptide/lipid ratios, membrane resistance to osmotic tension drops from hundreds to tens of milliosmoles. The actual decrease is dependent on the peptide/lipid ratio and on the type of lipid. We propose that under membrane tension a peptidic pore serves as a nucleation site for the transient formation of a lipidic pore. The tension is released upon pore expansion with inclusion of more peptides and lipids into the pore lining. This tension modulation of leakage was observed for other class L peptides (mastoparan, K18L) and thus may be of general applicability for the action of membrane active lytic peptides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463637      PMCID: PMC1301565          DOI: 10.1016/S0006-3495(01)75753-0

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  51 in total

Review 1.  Amphipathic helix motif: classes and properties.

Authors:  J P Segrest; H De Loof; J G Dohlman; C G Brouillette; G M Anantharamaiah
Journal:  Proteins       Date:  1990

2.  Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA.

Authors:  R A Parente; S Nir; F C Szoka
Journal:  Biochemistry       Date:  1990-09-18       Impact factor: 3.162

3.  Computer programs to identify and classify amphipathic alpha helical domains.

Authors:  M K Jones; G M Anantharamaiah; J P Segrest
Journal:  J Lipid Res       Date:  1992-02       Impact factor: 5.922

4.  Ion-channel properties of mastoparan, a 14-residue peptide from wasp venom, and of MP3, a 12-residue analogue.

Authors:  I R Mellor; M S Sansom
Journal:  Proc R Soc Lond B Biol Sci       Date:  1990-04-23

Review 5.  The biophysics of peptide models of ion channels.

Authors:  M S Sansom
Journal:  Prog Biophys Mol Biol       Date:  1991       Impact factor: 3.667

Review 6.  Prokaryotic osmoregulation: genetics and physiology.

Authors:  L N Csonka; A D Hanson
Journal:  Annu Rev Microbiol       Date:  1991       Impact factor: 15.500

7.  Dynamics of pore growth in membranes and membrane stability.

Authors:  W Sung; P J Park
Journal:  Biophys J       Date:  1997-10       Impact factor: 4.033

8.  Fluorescence assay for phospholipid membrane asymmetry.

Authors:  J C McIntyre; R G Sleight
Journal:  Biochemistry       Date:  1991-12-24       Impact factor: 3.162

9.  Antimicrobial activity of synthetic magainin peptides and several analogues.

Authors:  M Zasloff; B Martin; H C Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

10.  Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.

Authors:  M Zasloff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

View more
  15 in total

1.  Quartz crystal microbalance with dissipation monitoring of supported lipid bilayers on various substrates.

Authors:  Nam-Joon Cho; Curtis W Frank; Bengt Kasemo; Fredrik Höök
Journal:  Nat Protoc       Date:  2010-05-20       Impact factor: 13.491

2.  Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability.

Authors:  Nina E Golantsova; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  Early steps of supported bilayer formation probed by single vesicle fluorescence assays.

Authors:  Joseph M Johnson; Taekjip Ha; Steve Chu; Steven G Boxer
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

Review 4.  Toward understanding protocell mechanosensation.

Authors:  Daniel Balleza
Journal:  Orig Life Evol Biosph       Date:  2010-11-17       Impact factor: 1.950

5.  A vesicle bioreactor as a step toward an artificial cell assembly.

Authors:  Vincent Noireaux; Albert Libchaber
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-10       Impact factor: 11.205

Review 6.  Mechanisms of epithelial wound detection.

Authors:  Balázs Enyedi; Philipp Niethammer
Journal:  Trends Cell Biol       Date:  2015-03-24       Impact factor: 20.808

Review 7.  A common landscape for membrane-active peptides.

Authors:  Nicholas B Last; Diana E Schlamadinger; Andrew D Miranker
Journal:  Protein Sci       Date:  2013-06-11       Impact factor: 6.725

Review 8.  Mechanical forces in the immune system.

Authors:  Morgan Huse
Journal:  Nat Rev Immunol       Date:  2017-07-31       Impact factor: 53.106

9.  Steps towards the formation of a protocell: the possible role of short peptides.

Authors:  Maya Fishkis
Journal:  Orig Life Evol Biosph       Date:  2007-09-14       Impact factor: 1.950

10.  Polymeric crowding agents improve passive biomacromolecule encapsulation in lipid vesicles.

Authors:  Lisa M Dominak; Donna M Omiatek; Erica L Gundermann; Michael L Heien; Christine D Keating
Journal:  Langmuir       Date:  2010-08-17       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.